National Medical Products Administration, Guiding Principles of the Center for Medical Device Evaluation for Reviews for the Registration of Artificial Intelligence Medical Devices (2026 Revised Edition) (Draft for Comments)

国家药品监督管理局 医疗器械技术审评中心人工智能医疗器械注册审查指导原则 (2026年修订版) 征求意见稿

NMPA specifies the technical review requirements for artificial intelligence medical devices / Issued: 2026-09-14

By Susan Mok

Issued: September 14, 2026





Main contents: The objective of the Guiding Principles is to guide registration applicants in establishing life-cycle processes for artificial intelligence medical devices and preparing the materials required when filing for the registration of artificial intelligence medical devices.

Exclusive Content

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • Access to 3000+ essential documents, including key PRC laws translated into English
  • Newsletters with business-critical and sector-specific updates
  • Premium mobile access with timely analysis on China’s fast-changing market

Already a Subscriber? Log In Here

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)